tiprankstipranks
NKGen Biotech (NKGN)
NASDAQ:NKGN
US Market
Holding NKGN?
Track your performance easily

NKGen Biotech (NKGN) Income Statement

78 Followers

NKGen Biotech Income Statement

Last quarter (Q ), NKGen Biotech's total revenue was $―, a decrease of ― from the same quarter last year. In Q, NKGen Biotech's net income was $-16.09M. See NKGen Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21
Total Revenue
----
Cost of Revenue
----
Gross Profit
----
Operating Expense
$ 41.29M$ 29.75M$ 2.40M$ 2.14M
Operating Income
$ -41.19M$ -29.75M$ -2.74M$ -2.51M
Net Non Operating Interest Income Expense
$ -1.81M$ -745.00K$ 2.40M$ 41.15K
Other Income Expense
$ 40.14M$ 47.64M$ -5.28M$ -1.51M
Pretax Income
$ -95.02M$ -82.95M$ 4.99M$ -990.64K
Tax Provision
$ -683.77K$ 7.00K$ 438.37K-
Earnings From Equity Interest Net Of Tax
----
Net Income Common Stockholders
$ -88.25M$ -82.95M$ 4.84M$ -586.07K
Basic EPS
$ -5.08$ -5.38$ 0.21$ -0.07
Diluted EPS
$ -5.08$ -5.38$ 0.39$ -0.07
Basic Average Shares
$ 69.53M$ 15.43M$ 21.45M$ 15.08M
Diluted Average Shares
$ 69.53M$ 15.43M$ 21.45M$ 15.08M
Dividend Per Share
----
Total Operating Income As Reported
----
Reported Normalized Basic E P S
----
Reported Normalized Diluted E P S
----
Rent Expense Supplemental
----
Total Expenses
$ 41.34M$ 29.75M$ 2.40M$ 2.14M
Net Income From Continuing And Discontinued Operation
$ -88.25M$ -82.95M$ 4.55M$ -990.64K
Normalized Income
$ -33.59M-$ 3.94M$ -782.60K
Interest Expense
----
EBIT
$ -102.09M$ -77.39M$ 4.99M$ -990.64K
EBITDA
$ -101.05M$ -75.82M$ 4.99M$ -990.64K
Currency in USD

NKGen Biotech Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis